Literature DB >> 7032918

Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.

H T Mouridsen, M Salimtschik, P Dombernowsky, K Gelshoj, T Palshof, M Rorth, J L Daehnfeldt, C Rose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7032918

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

Review 1.  Endocrine therapy of metastatic breast cancer.

Authors:  A Manni
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

2.  On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.

Authors:  E Petru; D Schmähl
Journal:  Klin Wochenschr       Date:  1987-10-15

3.  Metastatic pattern and response to endocrine therapy in human breast cancer.

Authors:  C Kamby; C Rose
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.